Galectin Therapeutics
GALT
GALT
58 hedge funds and large institutions have $9.08M invested in Galectin Therapeutics in 2015 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 15 increasing their positions, 20 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
97% less call options, than puts
Call options by funds: $7K | Put options by funds: $224K
Holders
58
Holding in Top 10
–
Calls
$7K
Puts
$224K
Top Buyers
| 1 | +$428K | |
| 2 | +$248K | |
| 3 | +$203K | |
| 4 |
VKH
Virtu KCG Holdings
New York
|
+$183K |
| 5 |
Millennium Management
New York
|
+$130K |
Top Sellers
| 1 | -$1.26M | |
| 2 | -$669K | |
| 3 | -$538K | |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$316K |
| 5 |
Bank of New York Mellon
New York
|
-$141K |